Company intelligence / Profile preview

Quigley BioPharma

Bethesda, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Quigley BioPharma provides operational and scientific guidance to biotech and pharma clients in preclinical and clinical stages, mainly in infectious disease vaccines and biologics

Therapeutic areas: Infectious Diseases
Modalities: VaccinesMonoclonal antibodyImmunotherapyBiologicals
Industry: Consulting

Beyond the preview

Go deeper on Quigley BioPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quigley BioPharma.

Explore the full profile